Alisi_1995_Bioorg.Med.Chem.Lett_5_2077

Reference

Title : Synthesis and structure-activity relationships of new acetylcholinesterase inhibitors: Morpholinoalkylcarbamoyloxyeseroline derivatives - Alisi_1995_Bioorg.Med.Chem.Lett_5_2077
Author(s) : Alisi MA , Brufani M , Filocamo L , Gostoli G , Licandro E , Cesta MC , Lappa S , Marchesini D , Pagella P
Ref : Bioorganic & Medicinal Chemistry Lett , 5 :2077 , 1995
Abstract :

Several new potent acetylcholinesterase inhibitors have been synthesised as potential drugs for the meatment of Alzheimer's disease. Heptylphysostigmine (MF201) is a drug analogue of physostigmine under clinical evaluation. In order to obtain new physostigmine analogues, the metliylcarbamoyloxy group was substituted with co-morpholinoalkylcarbamoyloxy moieties of different chain lengths (C2-C12). Potent in vitro inhibition is seen when the chain length is composed of eight to twelve methylene groups. The inhibitory activity of the C10 and C11 is 7-fold greater with respect to heptylphysostigmin.

PubMedSearch : Alisi_1995_Bioorg.Med.Chem.Lett_5_2077
PubMedID:

Related information

Inhibitor MF231    MF217

Citations formats

Alisi MA, Brufani M, Filocamo L, Gostoli G, Licandro E, Cesta MC, Lappa S, Marchesini D, Pagella P (1995)
Synthesis and structure-activity relationships of new acetylcholinesterase inhibitors: Morpholinoalkylcarbamoyloxyeseroline derivatives
Bioorganic & Medicinal Chemistry Lett 5 :2077

Alisi MA, Brufani M, Filocamo L, Gostoli G, Licandro E, Cesta MC, Lappa S, Marchesini D, Pagella P (1995)
Bioorganic & Medicinal Chemistry Lett 5 :2077